NouvSoma-001

N/A

Report date: 2024/12/20 17:04:01

Base Information

Drug NameNouvSoma-001
Drug Alias Namehuman-induced neural stem cell-derived extracellular vesiclesNouvSoma001NouvSoma-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsIschemic StrokeNeuromyelitis Optica
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesiRegene Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiRegene Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeNeuromyelitis Optica
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A